Adults with mild Ebola virus disease who develop a concurrent bacterial co-infection require specific antibiotic management. This protocol addresses that distinct clinical sub-group.
This protocol applies to adult patients with confirmed Ebola virus disease at mild disease severity who present with evidence of a bacterial co-infection. Identifying and treating the bacterial component promptly is a key part of care in this population.
Management centres on a short course of oral antibiotic therapy targeting the bacterial co-infection. The complete regimen — including agent selection, schedule, and duration — is available in the full protocol.